Rituximab, Use and B Cell Depletion in Patients with Membranous Nephropathy– A Retrospective, Observational Study

[Image: see text] INTRODUCTION: Rituximab (Rtx), an anti-CD20 monoclonal antibody, results in selective B-cell depletion and has emerged as an important therapeutic option in idiopathic membranous nephropathy (MN). We conducted a retrospective observational study to evaluate the efficacy and tolerab...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaggar, Payal, Madipally, Ravitej, Raju, Sree B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593300/
https://www.ncbi.nlm.nih.gov/pubmed/37881741
http://dx.doi.org/10.4103/ijn.ijn_62_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593300/
https://www.ncbi.nlm.nih.gov/pubmed/37881741
http://dx.doi.org/10.4103/ijn.ijn_62_22

Ejemplares similares